| Financial Year |
March 31 2023 |
| Monetary Funds |
1,861,816,937.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
841,021.00 |
| Accounts Receivable |
890,769,599.92 |
| Advances to Suppliers |
34,034,186.01 |
| Other Receivables |
32,090,853.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
112,980,574.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
488,632.19 |
| Other Current Assets |
118,875,839.31 |
| Total Current Assets |
4,001,623,396.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,684,228,739.90 |
| Investment Properties |
892,406,912.02 |
| Fixed Assetes |
2,057,043,094.83 |
| Under-construction Projects |
333,758,722.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,710,672,163.40 |
| R&D expenses |
-- |
| Goodwill |
4,036,887.63 |
| Long-Term Deferred and Prepaid Expenses |
69,577,835.72 |
| Deferred Income Tax Assets |
96,811,631.92 |
| Other Non-Current Assets |
892,990,523.48 |
| Sub-Total of Non-Current Assets |
21,907,006,932.03 |
| Total Assets |
25,908,630,328.11 |
| Short-Term Loans |
1,293,202,774.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,231,487,226.75 |
| Accounts Received In Advance |
4,217,349.07 |
| Employee Compensation Payable |
178,227,129.20 |
| Taxes Payable |
29,349,280.26 |
| Interest Payable |
-- |
| Dividend Payable |
72,279,596.08 |
| Other payables |
583,603,343.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,164,250,041.81 |
| Other Current Liabilities |
598,610,670.46 |
| Sub-Total of Current Liabilities |
6,810,883,201.82 |
| Long-term Loans |
2,481,821,866.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
62,721,941.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,635,403.80 |
| Other Non-Current Liabilities |
110,751,897.07 |
| Sub-Total of Non-Current Liabilities |
2,840,276,845.10 |
| Total Liabilities |
9,651,160,046.92 |
| Paid-In Capital(Or Share Stock) |
1,475,111,351.00 |
| Capital Surplus |
1,827,124,337.24 |
| Surplus Reserve |
773,395,307.19 |
| LESS:Treasury Stock |
53,243,345.97 |
| Undistributed Profits |
11,175,372,224.23 |
| Minority Stockholder's Interest |
285,948,300.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,971,521,980.97 |
| Owner's Equity（Stockholder's Equity） |
16,257,470,281.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,908,630,328.11 |
